Novolog 100 unit/ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FJRK1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,825
Award facts
- Contract value 100% obligated
- $2,824.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $2,824.50 under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
This delivery order exemplifies AmerisourceBergen's critical role as a federal pharmaceutical distributor supporting military healthcare programs. The company's IDC with DLA enables flexible sourcing of a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The award of NovoLog, an insulin product for diabetes management, reflects the breadth of pharmaceutical commodities supplied through this arrangement. AmerisourceBergen's substantial contract portfolio with DLA demonstrates its capability to meet federal procurement requirements through competitive processes and maintain consistent supply of essential medications to support military personnel and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FJRK1?
SPE2DB25FJRK1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FJRK1 worth?
The government has obligated $2,825 on SPE2DB25FJRK1.
Is contract SPE2DB25FJRK1 an order under another contract?
Yes. SPE2DB25FJRK1 is a delivery order under SPE2DB22D2005, an indefinite delivery contract.
Was contract SPE2DB25FJRK1 competed?
The extent of competition for SPE2DB25FJRK1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award